[ij] [ij] [ij] 
Email id

Year : 2020, Volume : 13, Issue : 12
First page : ( 5806) Last page : ( 5810)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2020.01012.4

In-silico studies of novel triazole derivatives as inhibitor of 14a demethylase CYP51

Rao Shrusti1, Bhat Varadaraj1, Fathima Fajeelath1, Kumar Santosh1, Verma Ruchi1*

1Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Madhav Nagar-576104, Manipal, Udupi, Karanataka, India.

*Corresponding Author E-mail: ruchi.verma@manipal.edu

Online published on 15 February, 2021.


An antifungal agent is a drug that eliminates fungal pathogens selectively from host with negligible toxicity to the host. Antifungal agents are classified into classes like antibiotics, antimetabolite, azole, and allyl amine. In this present work, the binding mode of novel designed triazole analogues with CYP51 has been investigated by flexible molecular docking. The molecular modeling, which gives the utilization of structural information of CYP51 can enhance the discovery of novel antifungal agents. Further in silico studies were performed in order to see their drug likeness properties and possible mode of interaction with target protein residue. Molecular docking of novel molecules was done by Schrodinger software using following steps like protein preparation, ligand preparation, grid generation, molecular docking. The protein PDB selected was 5V5Z. AZ3 analogue showed the best dock score. The docking value varied from -2.578 to-8.19 for the designed ligands. All the molecules showed good ADME properties and followed Lipinski rule of five. The designed molecules can serve as a lead for future antifungal drug discovery.



Molecular docking, Triazole, Antifungal.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
751,753,291 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.